Is the price fair?
What DLB's price assumes
Dolby Laboratories, Inc. trades at 24.6× earnings against 33.6× for the median Specialty Business Services name, cheaper than its own group.
24.6
Trailing P/E · Specialty Business Services median 33.6 · cheaper than the typical name in its group
- Price / sales
- 4.04
Price / sales · as of 2026-Q1
- Free cash flow yield
- 6.1%
Free cash flow yield · Specialty Business Services median 4.7%
- Growth the price implies
- +3.1%
Growth the price implies · The price pays for +3.1% free cash flow growth a year for a decade; the business has delivered −4.7% a year over the last three.
Details›
- Price / book2026-Q1
- 2.10
- Industrials median P/E351 names
- 29.0
- Specialty Business Services median P/E21 names
- 33.6
- Free cash flow, trailing twelve months
- $301M
- Market capitalisation
- $4.96B
- 3-year free cash flow growth
- −4.7%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $69.18 |
| Its own P/E history, median | $82.85 |
| Its own P/E history, upper quartile | $92.06 |
| 52-week range | $48.51 – $74.34 |
| Today | $62.33 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Business Services
Ranks #6 of 18 by Smart Score